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ttp://dx.doi.org/10.1016/j.ajpath.2014.11.019Visceral fat necrosis has been associated with severe acute pancreatitis (SAP) for over 100 years; however,
its pathogenesis and role in SAP outcomes are poorly understood. Based on recent work suggesting that
pancreatic fat lipolysis plays an important role in SAP, we evaluated the role of pancreatic lipases in SAP-
associated visceral fat necrosis, the inﬂammatory response, local injury, and outcomes of acute pancreatitis
(AP). For this, cerulein pancreatitis was induced in lean and obese mice, alone or with the lipase inhibitor
orlistat and parameters of AP induction (serum amylase and lipase), fat necrosis, pancreatic necrosis, and
multisystem organ failure, and inﬂammatory response were assessed. Pancreatic lipases were measured in
fat necrosis and were overexpressed in 3T3-L1 cells. We noted obesity to convert mild cerulein AP to SAP
with greater cytokines, unsaturated fatty acids (UFAs), and multisystem organ failure, and 100% mortality
without affecting AP induction or pancreatic necrosis. Increased pancreatic lipase amounts and activity
were noted in the extensive visceral fat necrosis of dying obese mice. Lipase inhibition reduced fat necrosis,
UFAs, organ failure, and mortality but not the parameters of AP induction. Pancreatic lipase expression
increased lipolysis in 3T3-L1 cells. We conclude that UFAs generated via lipolysis of visceral fat by pancreatic
lipases convert mild AP to SAP independent of pancreatic necrosis and the inﬂammatory response.
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(V.P.S.).
Disclosures: None declared.Visceral fat necrosis has been noted to occur with pancre-
atitis for over 100 years.1,2 This fat is typically located in or
around the pancreas3,4 and is a major component of necro-
tizing pancreatitis and peripancreatic necrosis.5,6 Despite
being a part of the criteria for staging the severity of acute
pancreatitis (AP) in humans7e9 and being included as a
separate entity in the recently revised Atlanta criteria,6 the
pathogenesis and role of fat necrosis, that is, whether it is a
marker or mediator of severe AP (SAP), remains unclear.
Clinical correlates of the relevance of fat necrosis include
the several epidemiological studies that show individuals
with increased intra-abdominal fat10e13 or obese patients
being at an increased risk for SAP.11,14e20 Peripancreatic fat
necrosis may occur independent of pancreatic necrosis5 and
is associated with an increased risk for severe attacks.21,22stigative Pathology.
.Although there is basolateral leakage of pancreatic en-
zymes during pancreatitis,23e26 and lipases have been noted
in fat necrosis in human disease,27,28 it is unclear whether
these lipases cause fat necrosis or are a remnant of
pancreatic damage.
Triglycerides compose 80% to 90% of the volume of
adipocytes29e31 and can be hydrolyzed by lipases released
Fat Necrosis Worsens Pancreatitisbasolaterally during pancreatitis.23e26 Although in vitro
studies done more than 2 decades ago showed lipase inhi-
bition to reduce pancreatic acinar injury on co-incubation
with pancreatic homogenates and triglycerides,32 in vivo
lipase inhibition in SAP models showed no beneﬁt33 until
recently, when this was studied in the context of increased
visceral fat.34,35
Previous studies have shown that long-chain unsaturated
fatty acids (UFAs) form the majority of the nonesteriﬁed fatty
acids in necrotic collections36,37 and are more toxic than are
saturated fatty acids.32,34,35,38 Since obese (ob/ob) mice and
obese humans may have a similar visceral fat composi-
tion,3,35 we chose to study whether a classically mild model
of pancreatitis, that is, cerulein pancreatitis, would result in
different outcomes in these mice versus lean mice and
explore the role of fat necrosis in these outcomes. Our pre-
vious work has shown a beneﬁt of pharmacological inhibi-
tion of pancreatic lipases in biliary, IL-12einduced, and
IL-18einduced pancreatitis34,35; we therefore used this as a
tool to inﬂuence outcomes. Since obesity is also known to be
associated with an exaggerated baseline inﬂammatory state,
we went on to study whether the inﬂammatory response was
different between the groups that had different outcomes.
Additionally, since SAP may occur along with severe
pancreatic necrosis or with multisystem organ failure
(MSOF) with insigniﬁcant necrosis,39e41 we also compared
pancreatic necrosis between groups with different outcomes.
Reasons for preferring a pharmacological approach34,35
over a genetic one include: i) previous validation in mecha-
nistically distinct models,34,35 ii) the redundant roles of
pancreatic lipases42 (which are supported by this study), iii)
the deletion of the two lipases of interest being embryonically
lethal,43 and iv) the inability to make mice with a genetic
deletion of lipases obese on a high-fat diet (unpublished
data). Our results, in concert with those from previous
studies,34,35 show that pancreatic lipaseedependent visceral
fat lipolysis worsens outcomes of AP, unrelated to the initi-
ator of the disease, and suggest alternate ways to interpret the
parameters of severity in AP, along with suggesting a
potential approach to improving SAP outcomes.
Materials and Methods
Animal Studies
Male ob/ob (B6.V-lepob/J) mice or C57bl6 (lean) mice (8 to
10 weeks) were purchased from Jackson Laboratories (Bar
Harbor, ME) and were acclimatized for at least 2 days
before use. All animals were housed with a 12-hour light/
dark cycle at temperatures from 21C to 25C, fed standard
laboratory chow, and allowed to drink ad libitum. AP was
induced in lean (C57bl6) and ob/ob mice by hourly i.p.
injections of cerulein (50 mg/kg)  12 doses on 2 consec-
utive days (CR group). Obese mice were administered
orlistat [50 mg/kg b.i.d. in the CRO2 group (sacriﬁced at the
end of 2 days) and in the CRO5 group (sacriﬁced at the endThe American Journal of Pathology - ajp.amjpathol.orgof 5 days)] as described previously35 or its vehicle [10%
triolein in phosphate-buffered saline, 100 mL per 30 g body
weight in the CR þ vehicle (CRV) group] i.p. for 2 days.
The ﬁrst injection was administered 2 hours after the in-
duction of pancreatitis. The mice were followed up over a
course of 5 days or until they were moribund or died
overnight. Lean mice were also electively sacriﬁced at the
end of the ﬁrst 24 hours (CR1) or 48 hours after the ﬁrst
injection (CR2). Similarly, mice given orlistat (CRO2
group) were also electively sacriﬁced at 48 hours for com-
parison to the CR and CRV groups since 50% to 100% of
the mortality occurred in these groups at 48 hours. All of the
experiments were approved by the Institutional Animal Care
and Use Committee of the University of Pittsburgh (Pitts-
burgh, PA) and at the Mayo Clinic (Scottsdale, AZ).
Cytokine Assays
Cytokine assays were done as previously described,35,38
with the ﬂuorescence-based capture sandwich immuno-
assay based on the Luminex FlowMetrix system (Life
Technologies, Carlsbad, CA). The Milliplex mouse adipo-
kine panel (7-plex) 1 kit (Millipore, Billerica, MA) was used
for serum analysis. A Bio-Plex suspension array system,
including a ﬂuorescent reader and Bio-Plex Manager
analytical software version 200 (Bio-Rad Laboratories,
Hercules, CA), was used for analyzing samples at the
University of Pittsburgh Cancer Institute.
Evaluation of Pancreatic Necrosis and Special Stains
Whole pancreas section slides stained by hematoxylin and
eosin were examined by a trained morphologist (K.P.)
blinded to the sample as described previously.35,44 Brieﬂy,
all contiguous areas were imaged using a 4 objective and
photographed. Total fat area, necrotic fat area, perifat acinar
necrosis, and total acinar necrotic area were measured in
pixels as a percentage of total acinar area calculated for each
pancreas. Von Kossa staining was done as described pre-
viously.35,38 Staining with terminal deoxynucleotidyl
transferase dUTP nick end labeling was done on parafﬁn
sections of the lungs and kidneys as described previously.35
Serial sections of gonadal fat pads were stained with he-
matoxylin and eosin and von Kossa staining. Von Kossa
staining was done to detect calcium salts following the
manufacturer’s instructions (von Kossa stain kit, American
MasterTech, Lodi, CA).
Nonesteriﬁed Fatty Acid Analysis
Long-chain fatty acid was analyzed using gas chromatog-
raphy as described previously.35,38 UFA amounts were
calculated by adding individual C16:1, C18:1, C18:2, and
C20:4 fatty acids. Saturated fatty acid amounts were
calculated by adding individual C12:0, C14:0, C16:0, and
C18:0 fatty acids.809
Patel et alBiochemical Assays
Amylase, lipase, blood urea nitrogen, calcium, and glycerol
were measured following the manufacturer’s instructions
(Pointe Scientiﬁc, Inc., Canton, MI). Tests were performed
on a ChemWell-T Chemistry Analyzer (Awareness Tech-
nology, Palm City, FL).
Nuclear Magnetic Resonance Assessment of Visceral
Fat
The mice were weighed, and their whole-body fat and lean
tissue masses were determined using the MiniSpec Body
Composition Analyzer (Bruker Corporation, Billerica, MA)
based on nuclear magnetic resonance. The analyzer acquires
and analyzes time domainenuclear magnetic resonance
signals from all protons in the entire sample volume and can
provide the three components of interest: fat, free body
ﬂuid, and lean tissue values.
Western Blot Analysis
Gonadal fat pad or 3T3-L1 cells were homogenized in lysis
buffer containing a protease inhibitor cocktail (Complete,
EDTA Free; Roche, Mannheim, Germany). Lysates were
used for Western blot analysis after protein estimation with
a Pierce protein assay kit (Thermo Fisher Scientiﬁc,
Rockford, IL). Lysates from fat pads or 3T3-L1 were
analyzed by Western blots that were incubated with pri-
mary antibody [anti-hPTL (1:10,000; a kind gift from Dr.
Mark Lowe, University of Pittsburgh) and anti-hPLRP2
(1:400; SantaCruz Biotechnology, Dallas, TX)] and then
probed with horseradish peroxidase-labeled goat anti-
rabbit IgG and donkey anti-goat IgG (Millipore), respec-
tively. Bands were visualized by chemiluminescence using
electrogenerated chemiluminescence plus a Western
Blot Detection Kit (Amersham GE Healthcare, Buck-
inghamshire, UK).
Immunohistochemistry Analysis
The horseradish peroxidase immunohistochemistry tech-
nique was used for detecting CD11b, CD68, and myelo-
peroxidase in parafﬁn-embedded sections of gonadal fat
pads of obese mice. In brief, after deparafﬁnization and
antigen epitope retrieval, tissues were incubated with a rat
polyclonal antibody against CD11b (1:25, Developmental
studies hybridoma bank, Iowa City, IA), a rabbit polyclonal
antibody against CD68 (1:25; Abcam, Cambridge, MA), or
a rabbit polyclonal antibody against myeloperoxidase (1:50;
Abcam), followed by the application of horseradish perox-
idaseeconjugated (1:200; Millipore or Thermo Pierce Sci-
entiﬁc, Rockford, IL) secondary antibody. Staining was
completed with chromogen incubation with AEC substrate
kit for Peroxidase and Hematoxylin QS nuclear counterstain
(Vector Laboratories, Burlingame, CA).810Cell Culture of 3T3-L1 Adipocytes
3T3-L1 preadipocytes cells were obtained from American
Type Culture Collection (Manassas, VA). 3T3-L1 pre-
adipocytes were grown in 75 cm2 tissue culture ﬂask in Dul-
becco’s modiﬁed Eagle’s medium containing 10% bovine calf
serum in a humidiﬁed incubator at 37C with 5% CO2. For
adenoviral transduction experiment, differentiation was
induced using 3T3-L1 differentiation medium (ZenBio Inc.,
Research Triangle Park, NC). After cells reached conﬂuence,
cells were further maintained in the 3T3-L1 adipocyte medium
(ZenBio) for 10 to 12 days before adenoviral transfection. The
cDNA sequence corresponding to mouse pancreatic triglyc-
eride lipase (PTL) (GenBank; http://www.ncbi.nlm.nih.gov/
nuccore; Accession number NM_026925.3) and mouse
pancreatic lipase related protein-2 (PLRP2) (GenBank;
Accession number NM_011128.2) were cloned into pAdlox
vector to generate pAdlox/PTL or pAdlox/PLRP2 con-
structs. Adenoviruses of these constructs were generated at
the Vector Core Laboratory, University of Pittsburgh.
Mature 3T3-L1 adipocytes were transfected with 4  108
plaque-forming units per milliliter of recombinant PTL or
PLRP2 adenoviruses for their overexpression in the pres-
ence of 50 mmol/L adipose triglyceride lipase inhibitor
Atglistatin (Cayman Chemical Company, Ann Arbor, MI).
Eighteen hours after viral infection, media were collected
for the determination of lipase activity and glycerol level
while cells were processed for PTL or PLRP2 expression by
Western blot analysis.
Immunoﬂuorescence Studies
Immunoﬂuorescence studies were done on 3T3-L1 adipo-
cytes, cultured and adenovirally transfected as described in the
Cell Culture of 3T3-L1 Adipocytes section. Brieﬂy, cells were
ﬁxed with 2% paraformaldehyde, permeabilized, blocked with
5% normal goat serum, and exposed to an antibody against
PTL (1:500) for 1 hour. After three washes, goat anti-rabbit
Alexa Flour 594 (1:200; Invitrogen, Carlsbad, CA), and
high-content screening LipidTOX Red Neutral Lipid Stain
(1:200; Life Technologies) were added for 1 hour. After
washing, slides were mounted (Fluormount; Sigma-Aldrich,
St. Louis, MO) and imaged on a Zeiss Meta (LSM510)
confocal microscope using a 63 lens and 1-mm-thick optical
sections. Images were processed and analyzed using Photo-
shop CS4 (Adobe Systems, San Jose, CA).
Peripheral Blood Mononuclear Cell Experiments
Rodent blood collected by cardiac puncture was anti-
coagulated with isotonic EDTA, and erythrocytes were
removed by aggregation and sedimentation using 2%
methyl cellulose. The leukocyte-rich plasma was layered
over OptiPrep medium (Sigma-Aldrich) and centrifuged at
700  g for 20 minutes to separate peripheral blood
mononuclear cells as described by Boyum et al.45 Residualajp.amjpathol.org - The American Journal of Pathology
Figure 1 Pancreatic lipaseedependent release of UFAs from visceral fat necrosis causes CR pancreatitis to be lethal in ob/ob mice. Bar graphs of lean
(C57bl6) and ob/ob mice showing body weight (A), percentage composition (lean and fat) (B), and percentage triglyceride (TG) composition of gonadal
fat pads (C). ob/ob Mice with cerulein (CR) acute pancreatitis (AP) have elevated nonesteriﬁed fatty acids (NEFAs) (D) and unsaturated fatty acids (UFAs)
(E), but not saturated fatty acids (SFAs) (G), versus obese control (Con) or lean mice with CR AP for 1 or 2 days (CR1 and CR2, respectively). UFA levels are
reduced at day 2 (CRO2) and day 5 (CRO5) in ob/ob mice, and hypocalcemia is prevented (H), with orlistat use. Box plots show the means (dashed lines),
medians (solid lines), 25th and 75th percentiles (boxes), and 10th and 90th percentiles (brackets). F: Kaplan-Meyer 5-day survival curve showing 100%
mortality in ob/ob mice with CR with or without vehicle (CR and CRV, respectively) by day 3, which is improved to 80% survival (2/10 mortality) with
orlistat treatment. n  8 in each group. *P < 0.05 versus controls in the respective lean and ob/ob mice; yP < 0.05 versus ob/ob CR; zP < 0.05 for lean
CR1 versus ob/ob CR. Sr., serum.
Fat Necrosis Worsens Pancreatitiserythrocytes were lysed in isotonic ammonium chloride
solution. peripheral blood mononuclear cells were washed
and resuspended in serum-free RPMI 1640 media contain-
ing 25 mmol/L HEPES either alone or treated for 10 mi-
nutes with 10 mmol/L linoleic or oleic acid at 37C,
followed by labeling cells with using the ﬂuorescein
isothiocyanateeAnnexin V Apoptosis detection kit (BD
Pharmigen; BD Biosciences, San Jose, CA). Flow cytom-
etry was done on the BD LSR Fortessa Analyzer using the
BD FACSDiva software version 6.1.3 (BD Biosciences).
Acquisition was done after adjusting for forward and side
scatter voltages, selecting appropriate ﬂuorochrome chan-
nels using a minimum of 50,000 gated events per experi-
mental condition.
Graphical Depiction and Statistics
Summary statistics include means  SEM or 95% CIs, and/
or medians and interquartile ranges. Tests for proportionality
between groups were made using the c2 test. One-wayThe American Journal of Pathology - ajp.amjpathol.organalysis of variance was used for comparing differences
within a group. Pairwise comparisons between two groups
were made using Mann-Whitney U tests. All signiﬁcance
levels were evaluated at the two-tailed, P < 0.05 level.
Results
Cerulein Pancreatitis in ob/ob Mice with Increased
Visceral Unsaturated Triglycerides Causes 100%
Mortality and Increased Serum UFAs, Which Are
Reduced by Inhibition of Lipolysis
Initial comparison showed the ob/ob mice to weigh more
than the lean mice (42.7  2.6 g versus 26.4  0.5 g;
P < 0.001) (Figure 1A) and to have higher total body fat
(42.5%  3.8% versus 10.6%  0.6%; P Z 0.002)
(Figure 1B), consistent with previously published data.24
Although the fat pad triglyceride composition in lean mice
had equal proportions of saturated and unsaturated fat
(51.8%  3.9% and 48.1%  3.9%, respectively; PZ 0.5)811
Figure 2 Fat necrosis is mediated by active pancreatic lipases. A: Gross appearance of the peritoneal cavities in ob/ob mice show chalky white dotted areas
of saponiﬁcation (dashed red outlines) in the visceral fat pads of mice with pancreatitis  vehicle [cerulein (CR); CR þ Veh]. Fat necrosis is undetectable in
lean or orlistat-treated mice with pancreatitis (CR1 and CR þ Orli, respectively) despite all pancreatitis groups having pancreatic edema (yellow lines). B:
Western blots of the gonadal fat pads show increased, pancreatic lipaseerelated protein-2 (PLRP2) and pancreatic triglyceride lipase (PTL) in ob/ob mice with
pancreatitis sacriﬁced at day 2 [CR, CR vehicle (CRV)], irrespective of orlistat treatment (CRO), which apparently reduces the activity of pancreatic lipase in
these mice (C). Box plots show the means (dashed lines), medians (solid lines), 25th and 75th percentiles (boxes), and 10th and 90th percentiles (brackets).
n  6 in each group. *P < 0.05 versus controls; yP < 0.05 versus ob/ob CR. Con, control.
Patel et al(Figure 1C), the fat pads of ob/ob mice had 72.7%  0.4%
UFA, similar to the composition in humans who are obese
or have increased pancreatic fat.3,35
After the induction of cerulein pancreatitis, mice were
followed up for 5 days. Consistent with the lipolysis of the
visceral fat, a signiﬁcant increase in serum nonesteriﬁed fatty
acids (Figure 1D), UFAs (Figure 1E), and hypocalcemia
(Figure 1H), similar to human SAP46 were noted at the time
of mortality in ob/ob mice  vehicle versus control ob/ob or
lean mice on day 1 of AP (P < 0.02 in each case). The
increase in nonesteriﬁed fatty acids, UFAs, and hypocal-
cemia in ob/ob mice with AP were signiﬁcantly prevented
in the orlistat-treated group at day 2 and day 5 (P < 0.03
versus cerulein or vehicle treated groups in all cases).
Nonesteriﬁed saturated fatty acids did increase in the sera
of ob/obmice compared with those in controls but were not
signiﬁcantly different from those in any other group
(Figure 1G). There was 100% mortality by days 2 and 3,
respectively, in the ob/obmice with cerulein pancreatitis or
with vehicle treatment (ob/ob CR or ob/ob CRV)
(Figure 1F). In contrast, lean mice had no mortality and ob/
ob mice treated with orlistat (ob/ob CRO) had signiﬁcantly
reduced (20%) mortality (P Z 0.015). Calcium supple-
mentation normalized serum calcium but did not prevent
mortality.
Mortality in ob/ob Mice Is Associated with Pancreatic
Lipase-Induced Fat Necrosis
On necropsy, although the pancreata of the lean mice were
edematous (Figure 2A); there was no fat necrosis. In812contrast, ob/ob mice had gross evidence of visceral fat ne-
crosis, appearing as cheesy white droplets. This fat necrosis
was prevented in the mice that received orlistat.
Western blot analysis of necrosed fat pads revealed an
increased amount of PTL and PLRP2 in the areas of fat
necrosis despite orlistat treatment (CRO) (Figure 2B).
This increase was associated with an increase in pancre-
atic lipase activity (Figure 2C) in the fat pads of ob/ob
mice, which was prevented in the mice that received
orlistat.
To understand this further, we adenovirally overex-
pressed PTL or PLRP2 in 3T3-L1 cells (Figure 3). The
control 3T3-LI cells staining negative for pancreatic lipases
had several lipid droplets, with no cytoplasmic staining of
lipid. PTL or PLRP2 expression was associated with an
increase in pancreatic lipase activity (Figure 3, A, B, D, and
E) and lipolysis of the lipid droplets, evidenced by an in-
crease in glycerol release into the medium (Figure 3, F and
G), along with a progressive loss of lipid droplets
(Figure 3C), with increased cytoplasmic lipid staining. This
is mechanistically consistent with the in vivo observations
of elevated lipolytic products (Figure 1, D, E, and G) and
pancreatic lipase amounts in fat necrosis (Figure 2C) noted
in ob/ob mice.
ob/ob Mice Develop Sustained MSOF Secondary to
Lipotoxicity
Mortality from SAP in humans is associated with
MSOF alone or with pancreatic or peripancreatic
necrosis.6,14,21,22,35,38,41 We therefore assessed MSOF byajp.amjpathol.org - The American Journal of Pathology
Figure 3 Pancreatic lipases increase lipolysis in adipocytes. Adenoviral
expression of pancreatic triglyceride lipase (PTL) and pancreatic lipa-
seerelated protein-2 (PLRP2) in 3T3-L1 increases their protein expression
on Western blot analysis (A and B) associated with an increase in lipase
activity (D and E) and glycerol release into the medium (F and G). C:
Although control cells (yellow outlines), which do not express PTL or
PLRP2, exhibit several discreet lipid droplets in all the images, the
expression of PTL or PLRP2 causes a loss of this lipid-droplet morphology
and an increase in lipid staining in the cytoplasm. n  4 in each group.
*P < 0.05 versus controls. Original magniﬁcation, 60 (C).
Fat Necrosis Worsens Pancreatitisexamining evidence of kidney failure and apoptotic cells in
the lungs, which have previously been associated with lip-
otoxic acute respiratory distress syndrome.35,47e50
Obese mice with pancreatitis showed evidence of renal
tubular damage with several terminal deoxynucleotidyl
transferase dUTP nick end labelingepositive cells, which
were dramatically reduced in the orlistat-treated group
(Figure 4A). Serum blood urea nitrogen measurements in
lean mice and in orlistat-treated ob/ob mice with pancreatitisThe American Journal of Pathology - ajp.amjpathol.orgincreased transiently on day 1 and 2, respectively
(Figure 4B), normalizing later. However, the blood urea
nitrogen values in the obese mice with pancreatitis were
elevated at the time of mortality and were apparently un-
affected by the vehicle. Staining with terminal deoxy-
nucleotidyl transferase dUTP nick end labeling of the lungs
was dramatically increased in ob/ob mice dying with cer-
ulein pancreatitis (consistent with lipotoxic acute respiratory
distress syndrome35) and prevented by orlistat (Figure 4, C
and D). The induction of apoptosis by linoleic acid
(Figure 4F) and oleic acid (unpublished data) at low con-
centrations compared to controls (Figure 4E) supports the
lipotoxic role of UFAs in these outcomes. Thus the overall
picture suggests that mortality in ob/ob mice occurred from
renal failure and lipotoxic acute respiratory distress syn-
drome, which after lipase inhibition were improved and
similar to those in lean mice.
ob/ob Mice Have Increased Intrapancreatic Fat, Fat
Necrosis, and Associated Perifat Acinar Necrosis
Since obese humans have increased intrapancreatic fat
and increased fat necrosis, which contributes to the
damage of surrounding parenchyma, that is, perifat acinar
necrosis,35,38 we studied whether similar phenomena
occur in ob/ob mice.
Intrapancreatic fat occupied 33.9%  15.9% of the
pancreatic area in ob/ob mice, which was signiﬁcantly
higher compared with that in lean controls (3.6%  0.5%)
(P < 0.001). This fat was necrosed in the ob/ob mice but not
in lean mice (Figure 5A). A mean of 3.2%  2.1% of the
parenchyma immediately contiguous with the necrosed fat
also showed morphological evidence of necrosis (Figure 5,
B and C) and contributed to about half of the total necrotic
area (6.2  3.8%) in the obese mice, but not in the lean
mice, with pancreatitis (Figure 5, B and D). These results
were not affected in the vehicle-treated group. Fat necrosis
and perifat acinar necrosis were signiﬁcantly reduced in the
mice that received orlistat (Figure 5, AeC). Interestingly,
however, the amount of total acinar necrosis was not
signiﬁcantly affected by orlistat (Figure 5D). Consistent
with human data that serum amylase or lipase early in the
disease are unrelated to severity, on day 2 these were similar
in all groups with pancreatitis (Figure 5, E and F). However,
by the 5th day, these parameters were signiﬁcantly reduced
by orlistat treatment and were no different from those in ob/
ob controls, suggesting a signiﬁcant reduction in ongoing
pancreatic damage. These ﬁndings suggest that fat necrosis
may play a more important role in determining the outcomes
of pancreatitis than local pancreatic necrosis in this model.
Inhibition of Lipotoxicity Reduces Serum Cytokines by
Day 5 of Pancreatitis in ob/ob Mice
High serum IL-6, monocyte chemoattractant protein 1,
resistin, and tumor necrosis factor a are associated with SAP813
Figure 4 Lipase inhibition prevents MSOF. Representative images show that terminal deoxynucleotidyl transferase dUTP nick end labelingepositive cells
(arrows) increase in the kidney tubules of ob/obmice with cerulein (CR) acute pancreatitis (AP) vehicle (Veh) (A), and serum (Sr.) blood urea nitrogen (BUN)
(mg/dL) increases transiently in lean mice on day 1 and in ob/ob CR vehicle (CRV) mice at the time of mortality, which normalizes by day 5 of orlistat treatment
(B). C and D: Concentrations of terminal deoxynucleotidyl transferase dUTP nick end labelingepositive cells in the lungs of ob/ob mice with CR AP (arrows) are
reduced with orlistat use. Insets in C show the boxed area at higher magniﬁcation (100). Box plots show the means (dashed lines), medians (solid lines), 25th
and 75th percentiles (boxes), and 10th and 90th percentiles (brackets). The assessment of peripheral blood mononuclear cell (PBMC) apoptosis, indicated by
annexin V staining (and necrosis by increased propidium iodide staining), show increased early and late apoptosis induced by 10 mmol/L linoleic acid (LA) within
10 minutes of exposure (F) compared with control PBMC (E). n 8 in each group. *P< 0.05 versus controls (Con) in the respective lean and ob/obmice; yP< 0.05
versus ob/ob CR; zP < 0.05 for lean CR for 1 day versus ob/ob CR. Original magniﬁcation,10 (A and C). CR1, lean mice sacriﬁced at the end of day 1; CR2, lean
mice sacriﬁced at the end of day 2; CRO2, mice given orlistat and sacriﬁced at the end of 2 days; CRO5, mice given orlistat and sacriﬁced at the end of 5 days;
FITC-A, ﬂuorescein isothiocyanate A; HPF, high-power ﬁeld; PE-Tx-Red-YG-A, phytoerythrin-texas red-yellow green-A; Sr., serum.
Patel et alin humans and rodents.51e58 In the current studies, these were
signiﬁcantly higher in ob/ob mice ( vehicle) versus lean
mice with AP. IL-6 (Figure 6A), monocyte chemoattractant
protein 1 (Figure 6B), and tumor necrosis factor a (Figure
6D), but not resistin (Figure 6C) were increased in lean and
ob/ob mice versus controls and were unaffected by orlistat
treatment at 2 days. These concentrations, however, were
normalized on day 2 in lean mice and on the 5th day in
orlistat-treated ob/ob AP mice. Tumor necrosis factor a814showed a trend toward reduction but remained signiﬁcantly
elevated. Histologically, the necrosed fat pads showed an
increase in von Kossaepositive staining, suggesting sapon-
iﬁcation, which was prevented in the mice that received
orlistat (Figure 7A). However, like the serum cytokines, the
accumulation of myeloperoxidase (Figure 7A) or CD11b
(Figure 7B) positive cells on day 2 was unaffected with
orlistat use, whereas CD68-positive macrophages were
reduced, consistent with reduced fat necrosis (Figure 7B).ajp.amjpathol.org - The American Journal of Pathology
Figure 5 Lipase inhibition reduces pancreatic fat necrosis and perifat acinar necrosis but not pancreatic necrosis. The quantiﬁcation and images of fat
necrosis [amorphous deposits in necrotic intrapancreatic fat (IPF), in the ob/ob cerulein (CR)  vehicle (V) group] (A) and perifat acinar necrosis (PFAN) (B).
PFAN (dashed lines) is absent in lean mice and is reduced with orlistat (orli) use in ob/ob mice with AP (C). D: Pancreatic (Panc.) acinar necrosis is similar in all
groups with AP. Serum amylase (E) and lipase (F) are increased similarly in lean mice on day 1 and in ob/ob mice irrespective of orlistat treatment on day 2 or
at mortality. These concentrations are normalized by day 5 in surviving mice. *P < 0.05 versus controls in the respective lean and ob/ob mice; yP < 0.05 versus
ob/ob CR; zP < 0.05 for lean CR for 1 day versus ob/ob CR. Box plots show the means (dashed lines), medians (solid lines), 25th and 75th percentiles (boxes),
and 10th and 90th percentiles (brackets). n  8 in each group. Original magniﬁcation, 4 (C). CR1, lean mice sacriﬁced at the end of day 1; CR2, lean mice
sacriﬁced at the end of day 2; CRO2, mice given orlistat and sacriﬁced at the end of 2 days; CRO5, mice given orlistat and sacriﬁced at the end of 5 days; Veh,
vehicle.
Fat Necrosis Worsens PancreatitisDiscussion
Here, we note that pancreatic lipaseedependent lipolysis of
peripancreatic fatecontaining unsaturated triglycerides
causes fat necrosis, elevated UFAs, and MSOF independent
of the inﬂammatory response or pancreatic necrosis. Using a
classically mild model, we also learn that AP outcomes can
be unrelated to the initiator, with lipotoxicity being an
exacerbator, as may happen in hypertriglyceridemia or
obese patients, who are more prone to SAP.14e16,18,19 These
observations parallel and explain ﬁndings on human AP,
including the mechanisms of fat necrosis and the varied
outcomes in AP being unrelated to etiology, and they give
direction in choosing targets for improving AP outcomes.Pancreatic LipaseeDependent Lipolysis of Visceral Fat
Generates UFAs, Which Cause MSOF and Worsen AP
Studies on human tissue have shown evidence of pancreatic
lipases in fat adjacent to pancreatic tissues in patients with
AP.27,28 Basolateral leakage from acinar cells has also been
noted by separate groups23e26 in models simulating AP.
However it remains unclear whether this leakage of lipases
has a role in fat necrosis or is a mere marker of enzymesThe American Journal of Pathology - ajp.amjpathol.orgleaked from a dying pancreas into the surrounding fat.
Using an in vitro acinar-adipocyte coculture system, we
previously showed an increase in lipase activity in the
adipocyte compartment to be associated with an increase in
nonesteriﬁed fatty acids in the acinar compartment, resulting
in acinar cell death.38 Causality between the increase in
nonesteriﬁed fatty acids and acinar cell death has been
established in previous studies the showing prevention of
such phenomena by inhibiting pancreatic lipases.32,35 Here
we note induction of apoptosis soon after exposure of pe-
ripheral blood mononuclear cells to UFA. Mechanistically
prolonged UFA exposure has been shown to inhibit mito-
chondrial complexes I and V.35 These ﬁndings would be
consistent with a necroapoptotic mode of cell death induced
by UFA.
Here, using ob/ob mice that have increased visceral fat
enriched in unsaturated triglyceride, similar to obese
humans,3,34,35 we note increased amounts of pancreatic
lipases in AP-associated fat necrosis. This increase in
pancreatic lipases likely occurs due to leakage from the
inﬂamed pancreas since we could not detect an increase in
the mRNA of pancreatic lipases in fat necrosis. These
lipases cause lipolysis of the stored triglyceride in the fat,
resulting in an increase in serum UFA. Using 3T3-L1 cells,
we note that increasing pancreatic lipase amounts results in815
Figure 6 Serum cytokine concentrations are
greater in ob/ob mice and unaffected by lipase
inhibition early in the disease. Box plots depicting
serum IL-6 (A), monocyte chemoattractant protein
1 (MCP-1) (B), resistin (C), and tumor necrosis
factor (TNF)-a (D) being signiﬁcantly higher in ob/
ob mice versus lean mice. These concentrations are
unaffected with orlistat treatment on day 2 and
are reduced by day 5. *P < 0.05 versus controls in
the respective lean and ob/ob mice; yP < 0.05
versus ob/ob cerulein (CR); zP < 0.05 for the lean
CR for 1 day versus ob/ob CR. Box plots show the
means (dashed lines), medians (solid lines), 25th
and 75th percentiles (boxes), and 10th and 90th
percentiles (brackets). n  8 in each group. CR1,
lean mice sacriﬁced at the end of day 1; CR2, lean
mice sacriﬁced at the end of day 2; CRO2, mice
given orlistat and sacriﬁced at the end of 2 days;
CRO5, mice given orlistat and sacriﬁced at the end
of 5 days; Veh, vehicle.
Patel et alincreased pancreatic lipase activity and lipolysis of the lipid
droplets stored in these cells, similar to ob/ob mice that have
an increase in serum UFA secondary to pancreatic lipasee
mediated fat necrosis. The role of pancreatic lipases medi-
ating UFA lipotoxicity via fat necrosis is supported by the
following: i) the lack of lung injury, hypocalcemia, and
sustained renal failure in lean mice and orlistat-treated ob/ob
mice that have no fat necrosis, ii) clinical observations that
SAP patients have elevated UFAs in the serum,59 iii) hy-
pocalcemia is a part of the criteria predictive of SAP,60 iv)
UFAs cause hypocalcemia46 (please note that preventing
hypocalcaemia by supplementing calcium did not improve
outcomes), v) i.v. oleic acid results in acute lung
injury,47e50 vi) UFAs cause renal tubular toxicity,61,62 and
vii) i.v. oleic acid results in renal failure.48 This spectrum of
end points secondary to UFAs and our ﬁndings in Figure 4816support their role in MSOF and as a target of improving
SAP outcomes.
Visceral Fat Necrosis May Worsen Inﬂammation and
Outcomes Independent of Etiology or Pancreatic
Necrosis
Although both lean and ob/ob mice used in this study
fulﬁlled the clinical criteria for the diagnosis of AP,63 lean
mice developed AP, mild hypercytokinemia, and transient
single organ failure, with no mortality over the 3 to 5 days
they were followed, thus behaving like the classically mild
cerulein pancreatitis64 reported in the literature so far. In
contrast, ob/ob mice, despite the similar increases in serum
amylase and lipase, died from the complications described
in the Results section. These ﬁndings are supported byFigure 7 Acute inﬂammatory cell inﬁltration of
fat in ob/ob mice with AP is unaffected by lipase in-
hibition. A: Serial sections of ob/ob gonadal fat pads
show fat necrosis as browneblack staining (Von-
Kossa) and amorphous blue appearance (hematoxylin
and eosin) corresponding to saponiﬁed fatty acids,
which are reduced with orlistat (Orli) use. However,
serial sections of inﬂammatory cell inﬁltrates
(insets), positive for myeloperoxidase (MPO), are
unaffected with orlistat use. B: Images and magniﬁ-
cations of immunohistochemistry analysis of CD11b-
positive cells show these to be unaffected by lipase
inhibition, whereas CD68 positivity is reduced in the
orlistat-treated group (cerulein [CR] þ Orli). Boxed
areas shown at higher magniﬁcation below. Original
magniﬁcation:10 (top two rows, A);40 (bottom
two rows, A; ﬁrst and third rows, B);100 (second
and fourth rows, B).
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Fat Necrosis Worsens Pancreatitisprevious studies showing lipotoxicity to worsen AP out-
comes independent of etiology.34,35
Consistent with clinical literature on obese patients,51e58
serum cytokines were higher in ob/ob mice with SAP than
in the lean mice with mild AP. Interestingly, serum cyto-
kines were unaffected by orlistat treatment in the ob/ob mice
electively sacriﬁced on day 2 of AP. Similarly, lipase in-
hibition, which decreased fat necrosis and improved out-
comes, did not affect inﬁltration of fat by myeloperoxidase-
and CD11b-positive cells. This ﬁnding may be due to the
exaggerated pro-inﬂammatory state in obesity independent
of UFA lipotoxicity. The improved survival with lipase
inhibition suggests that the increased inﬂammatory response
is a severity marker but not a severity mediator and is
supported by the eventual reduction in serum cytokines in
orlistat-treated mice electively sacriﬁced on the 5th day.
Support for cytokines being SAP markers comes from the
following: i) increases in serum IL-6 and tumor necrosis
factor a secondary to UFAs,49 ii) mice administered IL-6 do
not develop organ failure,65 iii) Il6 knockout mice develop
SAP,65 iv) studies showing these cytokines have a protec-
tive role in AP and organ failure,66,67 and v) previous
studies showing UFAs to up-regulate cytokines.35
Here we also note that the median necrosis was <10% in
both the lean and ob/obmice, similar toﬁndings fromprevious
reports,68 and is unaffected by lipase inhibition which pre-
ventsMSOF andmortality. These ﬁndings are is in agreement
with those in humans, in whom mortality may occur with
minimal or undetectable pancreatic necrosis39e41 and in
contrast to animal models, in which severity has conven-
tionally been graded by the extent of pancreatic necrosis,64
such as in the mouse cerulein model versus the rat model.69
Our current ﬁndings would therefore be consistent with the
clinical observations that, during AP, failing organ systems
portend a worse outcome even in the absence of necrosis.
In summary, pancreatic lipaseedependent generation of
UFAs from fat necrosis causes MSOF, independent of
pancreatic necrosis and inﬂammation, converting mild AP
to SAP. Therefore, targeting UFA-mediated lipotoxicity,
rather than the inﬂammatory response may be a better op-
tion for improving outcomes in SAP in obesity.
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